top of page
>
>
Market forecast and technology valuation for a novel immuno-oncology cell therapy
Client Problems
- A UniveristyTechnical Transfer Office wants to analyze an internal novel cell therapy product indicated for several cancers
- They wanted to prioritize the indications and understand the potential market over 20 years for the product across different geographies, including US, EU, Japan and China.
- The client wanted to negotiate the licensing of the technology based on the market forecast and previous licensing deals
What We Did
- Determined the top indication for the product and created a patient flow to determine the therapeutic opportunities
- We created a sales prediction model for the cell therapy in different geographies, accounting for loss of patent exclusivity and pricing regulations in these geographies
- We performed sensitivity analysis to account for different variabilities
- We analyzed comparable deals and trends in the therapeutic space
Our Results And Insight
- Patient flow and segmentation to determine therapeutic opportunity
- Value unwind shows impact of PTS at each stage of development
- Sensitivity analysis to account for treated Population, growth rate and pricing
- Analysis of relevant comparable licensing deals
See other case studies
Commercial Strategy case studies >
Oncology case studies >
Service Areas Details
Commercial Strategy (Valuation and Market Forecast)
Therapeutic Areas Details
Oncology (Cell Therapy, Hematology)
Featured Consultants
bottom of page